Nuformix PLC (NFX)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
0.16p
Buy
0.165p
0.0692p (+72.84%)
Prices updated at 28 May 2025, 17:26 BST
| Prices minimum 15 mins delay
Prices in GBX
Nuformix PLC is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved drugs with lead programmes in oncology supportive care and fibrosis.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
0.18p - 0.09p | |
0.30p - 0.04p | |
- | |
1.61m | |
- | |
2,000,000 | |
795,884,191 | |
1.99 | |
31,804,233.51 | |
2.88 | |
819.31m | |
GB00BYW79Y38 | |
0.00 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.